Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome

Volume 23, Issue 2, February 2022, Pages 591-599

Nigel P Murray; Ricardo Villalon; Dan Hartmann; Patricia Maria Rodriguez; Socrates Aedo

• View Article
• PDF 646.56 K

Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma

Volume 18, Issue 6, June 2017, Pages 1671-1674

Sakkarn Sangkhamanon; Piangpen Jongpairat; Aumkhae Sookprasert; Kosin Wirasorn; Attapol Titapun; Ake Pugkhem; Piti Ungareevittaya; Jarin Chindaprasirt

• View Article
• PDF 473.72 K

The Pre-Treatment Neutrophil-Lymphocyte Ratio: a Useful Tool in Predicting Non-Sentinel Lymph Node Metastasis in Breast Cancer Cases

Volume 18, Issue 2, February 2017, Pages 557-562

Suphawat Laohawiriyakamol; Somrit Mahattanobon; Supparerk Laohawiriyakamol; Puttisak Puttawibul

• View Article
• PDF 288.45 K

Elevated Neutrophil-to-Lymphocyte Ratio in Squamous Cell Carcinoma of Larynx Compared to Benign and Precancerous Laryngeal Lesions

Volume 15, Issue 17, December 2014, Pages 7351-7355

• View Article
• PDF 415.35 K

Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?

Volume 15, Issue 15, December 2014, Pages 6375-6379

• View Article
• PDF 496.17 K

The Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib

Volume 14, Issue 9, September 2013, Pages 5527-5531

• View Article
• PDF 480.13 K